|
Temps réel estimé
Cboe BZX
16:44:28 04/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 13,84 USD | +0,07% |
|
-0,75% | +164,53% |
| 11/08 | Immix Biopharma, Inc. : Morgan Stanley reste à l'achat | ZM |
| 07/08 | Immix Biopharma, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,07% | -0,75% | +48,29% | +64,31% | +164,53% | +531,74% | +464,69% | - | - | 989 M | |
| +0,41% | -2,07% | +21,89% | +58,45% | +72,80% | +41,26% | +95,40% | +17,15% | - | 69,02 Md | |
| -1,89% | -0,11% | +22,83% | +22,69% | +24,75% | +41,62% | +88,29% | +201,18% | +6 278,03% | 66,32 Md | |
| -0,07% | +7,11% | +28,57% | +21,01% | -27,05% | -10,92% | +381,48% | +351,19% | +827,43% | 27,66 Md | |
| +1,00% | +1,03% | +12,90% | +15,11% | +8,33% | -0,36% | -15,47% | -70,25% | - | 25,84 Md | |
| -3,00% | -2,90% | +21,55% | +51,70% | +56,42% | +39,40% | +9,41% | -59,12% | - | 26,54 Md | |
| -0,93% | +1,07% | +16,03% | +37,61% | +7,50% | +24,87% | -18,17% | -29,71% | +106,54% | 20,4 Md | |
| +3,45% | -13,46% | +15,88% | +66,58% | +218,62% | +222,69% | +389,50% | +1 726,21% | +925,83% | 17,63 Md | |
| -1,49% | -4,88% | +1,58% | +25,42% | +24,78% | -0,41% | +530,26% | - | - | 15,15 Md | |
| -0,69% | +7,73% | +4,75% | +11,75% | +33,84% | +56,93% | +163,40% | +200,51% | +385,60% | 14,65 Md | |
| -0,67% | +1,83% | +7,09% | +10,29% | -6,66% | +26,05% | +194,60% | +582,07% | +4 783,56% | 12,54 Md | |
| -1,60% | +0,48% | -4,77% | +13,51% | +28,51% | +204,70% | +204,37% | +30,01% | +1 091,55% | 12,22 Md | |
| +1,26% | +24,91% | +24,64% | +15,57% | -1,94% | -27,94% | +992,36% | +153,70% | +159,85% | 13,67 Md | |
| +11,45% | +6,14% | +7,83% | +1,76% | -10,44% | -31,25% | +187,50% | +135,08% | - | 10,67 Md | |
| -1,28% | +1,76% | -6,68% | +1,48% | +15,45% | +47,46% | +108,65% | +136,26% | +619,22% | 10,28 Md | |
| +0,47% | +2,57% | +12,21% | +25,86% | +33,01% | +90,89% | +20,33% | +136,95% | - | 9,1 Md | |
| -1,48% | -4,53% | -0,62% | +10,50% | +11,11% | -11,55% | +125,35% | -28,25% | - | 8,87 Md | |
| -0,79% | +0,56% | +16,47% | +11,04% | +308,84% | +238,70% | +454,45% | -28,11% | - | 8,68 Md | |
| 0,00% | -3,56% | -16,96% | +11,03% | +166,00% | +412,89% | +484,93% | -54,32% | -49,99% | 7,69 Md | |
| +0,93% | -3,45% | +4,91% | +31,36% | +6,65% | -6,10% | +261,47% | +268,55% | - | 7,44 Md | |
| Moyenne | +0,25% | -1,36% | +11,92% | +25,35% | +56,75% | +94,53% | +256,14% | +203,84% | +1 512,76% | 19,27 Md | |
| Moyenne pondérée par Capi. | -0,17% | -0,70% | +15,58% | +30,44% | +45,06% | +53,61% | +188,81% | +185,70% | +2 683,24% |
- Bourse
- Actions
- Action IMMX
- Secteur Immix Biopharma, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
